title: Contraindicated use of 5-alpha-reductase inhibitors in women.
authors: Royal Dutch Association for the Advancement of Pharmacy, Postbus 30460, 2500 GL, Den Haag, the Netherlands.|Department of Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
authors: Martina
authors: M
authors: Teichert
authors: Netherlands Pharmacovigilance Centre Lareb, s'Hertogenbosch, the Netherlands.
authors: Eugene
authors: E
authors: van Puijenbroek
authors: Inspectorate of Health Care, Postbus 2680, 3500 GR, Utrecht, the Netherlands.|Department of Epidemiology, Erasmus Medical Center, PO Box 2040, 3000 DR, Rotterdam, the Netherlands.
authors: Bruno H
authors: BH
authors: Stricker
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000009:adverse effects*; D000014:Abnormalities, Drug-Induced / Q000209:etiology* / Q000517:prevention & control; D000293:Adolescent; D000328:Adult; D000075203:Contraindications, Drug; D011307:Drug Prescriptions / Q000592:standards / Q000706:statistics & numerical data; D000068538:Dutasteride / Q000009:adverse effects; D005260:Female; D018120:Finasteride / Q000009:adverse effects; D005837:Genitalia, Male / Q000002:abnormalities*; D006801:Humans; D008297:Male; D018811:Maternal Exposure / Q000009:adverse effects*; D008875:Middle Aged; D009426:Netherlands; D011247:Pregnancy; D012737:Sex Factors; D013739:Testosterone / Q000378:metabolism*; D055815:Young Adult
chemical_list: D058891:5-alpha Reductase Inhibitors; D013739:Testosterone; D018120:Finasteride; D000068538:Dutasteride